MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by OLSEN, R. W.
Right arrow Articles by BAN, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OLSEN, R. W.
Right arrow Articles by BAN, M.

Molecular Pharmacology, Vol 11, 558-565, Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics

Potency of Inhibitors for ggr-Aminobutyric Acid Uptake by Mouse Brain Subcellular Particles at 0°

RICHARD W. OLSEN 1, J. DOUGLAS BAYLESS 1, and MATT BAN 1

1 Department of Biochemistry, University of California, Riverside, California 92502

Binding of ggr-amino[14C]butyric acid by sucellular particles of mouse brain homogenates at 0° is apparently due to action of the specific transport system for GABA. Although not energy-requiring, this uptake process showed a saturable dependence of GABA concentration, with an apparent Km of 28 ± 3 µM. The process was strictly sodium-dependent and sensitive to osmotic shock, freezing and thawing, and treatment with mild detergents. None of the GABA sequestering had the properties expected of neurotransmitter receptor sites, which probably were present in concentrations too low to be detectable by equilibrium dialysis of filtration assays of ligand binding. The potency of inhibition of GABA uptake at 0° was determined for 13 structural analogues of GABA known to inhibit both the transport of GABA and GABA synapses. No inhibition of GABA uptake occurred with 0.3 mM picrotoxin, but high concentrations (0.3 mM) of bicuculline-like compounds did inhibit the process, indicating that inhibition of the "binding" of radioactive GABA to tissue homogenates by bicuculline is not a sufficient criterion by itself to define such binding sites as receptors.

Note:
ACKNOWLEDGMENTS We thank Drs. Michael F. Dunn, Clement E. Furlong, Randall C. Willis, Thomas Miller, and Ning G. Pon for helpful discussions. The gift of several compounds from Dr. Graham Johnston is gratefully acknowledged.

Submitted on December 6, 1974







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1975 by the American Society for Pharmacology and Experimental Therapeutics